"Metro Pain Group are global leaders in the field of pain management. Our team of expert practitioners aim to enhance our patients’ quality of life through the reduction of acute, chronic and complex pain. Our integrated approach to pain encompasses the recognition and management of biopsychosocial factors through the collaboration of our multidisciplinary team comprising of doctors, physician associates, nurses, psychologists and a rehab coordinator. As pioneers in pain management, we offer advanced, innovative and evidence-based therapies tailored to suit individual patients and deliver exceptional patient experience by adopting excellent practices in all aspects of patient care."

During the past decade, Metro Pain Group conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Metro Pain Group" are "Chronic Pain" (1 trials) and "Neuropathic Pain" (1 trials). Many other conditions were trialed in "Metro Pain Group" in a lesser frequency.

Most popular intervention types in "Metro Pain Group" are "Biological" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Dorsal root ganglion stimulation (DRG)" (1 trials), "Placebo" (1 trials), "Spinal cord stimulation (SCS)" (1 trials) and "XT-150" (1 trials). Other intervention names were less common.

The vast majority of trials in "Metro Pain Group" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Metro Pain Group". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Metro Pain Group, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Metro Pain Group, 1 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".